We proposed to perform a prospective randomized controlled trial to study the effect of the
use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of
central venous catheter care on catheter-related bloodstream infections among patients in
two Barnes-Jewish Hospital ICUs.
- patients who are admitted to the ICU with a central venous catheter (i.e. triple
lumen catheters, quadruple lumen catheters, percutaneously inserted central
catheters, arterial catheters, intraaortic balloon pumps, Swan-Ganz catheters).
- patients who are not enrolled into the trial within 7 days of having the catheter
being placed and patients who are allergic to chlorhexidine.